Benzocaine Topical Gels and Ointments manufacturers & suppliers

Benzocaine Topical Gels And Ointments

Form: Topical Gels and Ointments

Strength: 10%, 15%, 20%

Reference Brands: Anbesol, Cepacol, Orajel, Socor(US)

Category: Analgesic

Benzocaine topical gels and ointments are approved in both the EU and US for localized pain relief and mucosal anesthesia. In the EU, brands like Orabase are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data and safety evaluations, with many generic formulations available. Both regions enforce strict labeling, usage guidelines, and safety monitoring due to potential side effects like methemoglobinemia. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for benzocaine gels and ointments, ensuring adherence to European and US standards for safe, effective topical anesthesia.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Paracetamol (Acetaminophen) Injection

Strength: 1000 mg/100 mL (10 mg/mL)

Form: Injectable solution

Reference Brands: Ofirmev

View Details
Dexketoprofen + Tramadol Tablets

Strength: 25 mg dexketoprofen + 37.5 mg tramadol

Form: Tablets

Reference Brands: Enantyum(EU)

View Details
Paracetamol + Codeine Tablets

Strength: 300 mg paracetamol + 30 mg codeine; 300 mg + 60 mg

Form: Tablets

Reference Brands: Tylenol with Codeine(US)

View Details
Aceclofenac + Paracetamol Tablets

Strength: 100 mg Aceclofenac + 325 mg Paracetamol

Form: Tablets

Reference Brands: Generic formulations marketed under different names

View Details

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.